Scalagen is an independent advisory practice providing fractional business development and corporate development leadership to biotech and life-science companies. We support senior management on licensing strategy, strategic transactions and independent transaction review / second opinion mandates.

We help organisations translate strategic clarity into structured partnering outcomes without the cost or commitment of a full-time hire.

Our work typically falls into four engagement models:

• Advisory Sessions — Focused strategic discussions to refine decisions, test transaction structures or challenge assumptions
• Strategic Assessment & Partner Readiness — Structured work to sharpen asset positioning, partnering strategy and execution priorities
• Transaction Leadership — End-to-end support across partner engagement, licensing negotiations, due diligence and deal execution
• Independent Transaction Review — Objective evaluation of deal structure, valuation, risk allocation and long-term alignment

Scalagen engagements are confidential, mission-based and advisory in nature. We prioritise decision quality, transaction discipline and sustainable value creation.

Scalagen

Org chart

Teams

Offices